Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (methyl-onn-azoxy)methanol Acetate
2. Acetate, Methylazoxymethanol
3. Methylazoxymethanol Acetate
1. Methylazoxymethanol Acetate
2. 592-62-1
3. Methylazoxy Methanol Acetate
4. Dtxsid1025568
5. Akos006282597
| Molecular Weight | 132.12 g/mol |
|---|---|
| Molecular Formula | C4H8N2O3 |
| XLogP3 | -0.3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 132.05349212 g/mol |
| Monoisotopic Mass | 132.05349212 g/mol |
| Topological Polar Surface Area | 67.4 Ų |
| Heavy Atom Count | 9 |
| Formal Charge | 0 |
| Complexity | 132 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Neurotoxins
Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept. (See all compounds classified as Neurotoxins.)
Nucleic Acid Synthesis Inhibitors
Compounds that inhibit cell production of DNA or RNA. (See all compounds classified as Nucleic Acid Synthesis Inhibitors.)
Protein Synthesis Inhibitors
Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)
IN RATS INJECTED WITH (3)H-METHYLAZOXYMETHANOL ACETATE ON DAY 14 OF PREGNANCY, 4% OF INJECTED RADIOACTIVITY WAS FOUND IN FETUSES; RADIOACTIVITY WAS ALSO FOUND IN LIVER & KIDNEY OF TREATED MOTHERS. DNA & RNA FROM FETAL BRAIN CONTAINED GUANINE METHYLATED IN 7-POSITION.
IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V10 133 (1976)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Cycasin Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cycasin Acetate, including repackagers and relabelers. The FDA regulates Cycasin Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cycasin Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cycasin Acetate supplier is an individual or a company that provides Cycasin Acetate active pharmaceutical ingredient (API) or Cycasin Acetate finished formulations upon request. The Cycasin Acetate suppliers may include Cycasin Acetate API manufacturers, exporters, distributors and traders.
Cycasin Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cycasin Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cycasin Acetate GMP manufacturer or Cycasin Acetate GMP API supplier for your needs.
A Cycasin Acetate CoA (Certificate of Analysis) is a formal document that attests to Cycasin Acetate's compliance with Cycasin Acetate specifications and serves as a tool for batch-level quality control.
Cycasin Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Cycasin Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cycasin Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Cycasin Acetate EP), Cycasin Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cycasin Acetate USP).
LOOKING FOR A SUPPLIER?
